title: Prolonged propionyl-L-carnitine pre-treatment of rabbit: biochemical, hemodynamic and electrophysiological effects on myocardium.
abstract: Recently it has been reported that prolonged treatment with propionyl-L-carnitine, a carnitine derivative, results in a positive inotropic effect. To gain further insight into its mode of action, we pre-treated 253 rabbits for up to 10 days with daily doses of 1 mmol/kg propionyl-L-carnitine or L-carnitine intraperitoneally, using saline-treated animals as control. Twenty-four hours after the last injection, we isolated papillary muscles for electrophysiological investigations. Whole hearts were used in perfusion experiments for biochemical and hemodynamic measurements. In addition, mitochondria were harvested from these hearts for the analysis of their function. Plasma and cardiac levels of free carnitine, along with plasma short-chain acylcarnitines, increased at least two-fold after treatment with carnitine or its propionyl-ester, with concomitant rises in tissue long-chain acylcarnitine and long-chain acyl-CoA. At the time of animal sacrifice, treatment did not increase plasma or tissue propionyl-L-carnitine content. The studies carried out with perfused hearts and isolated mitochondria failed to show an effect of propionyl-L-carnitine pre-treatment on high-energy phosphate metabolism or respiration. Papillary muscles from animals, treated for 10 days, showed a lengthening of the action potential duration from 63 +/- 4 to 102 +/- 6 ms (P less than 0.001) at -10 mV. Perfused hearts from these rabbits displayed positive inotropy, as indicated by an improved pressure development at higher ventricular filling volumes, e.g., from 39 +/- 4 to 60 +/- 3 mmHg (P less than 0.05) at 3.6 ml. Pre-treatment with L-carnitine or saline failed to affect the electrophysiological and hemodynamic variables. Thus, prolonged treatment of rabbits with propionyl-L-carnitine, but not with L-carnitine, improved contractility and lengthened action potential duration in isolated muscle preparations.
authors.affiliation: University of Brescia, School of Medicine, Chair of Cardiology, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Ferrari
authors.forename: F
authors.initials: F
authors.lastname: Di Lisa
authors.forename: J W
authors.initials: JW
authors.lastname: de Jong
authors.forename: C
authors.initials: C
authors.lastname: Ceconi
authors.forename: E
authors.initials: E
authors.lastname: Pasini
authors.forename: R
authors.initials: R
authors.lastname: Barbato
authors.forename: R
authors.initials: R
authors.lastname: Menabò
authors.forename: M
authors.initials: M
authors.lastname: Barbieri
authors.forename: E
authors.initials: E
authors.lastname: Cerbai
authors.forename: A
authors.initials: A
authors.lastname: Mugelli
mesh_terms: D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D002331:Carnitine / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism / Q000494:pharmacology; D004594:Electrophysiology; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D006439:Hemodynamics / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism; D010210:Papillary Muscles / Q000187:drug effects / Q000502:physiology; D010477:Perfusion; D011817:Rabbits
chemical_list: C003223:propionylcarnitine; D002331:Carnitine